Available Technologies
Technologies by Dr. Meghan O'Melia
Developing Tumor Immune Microenvironments via Engineered Hydrogel
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
8785
Learn more about Dr. Meghan O'Melia